+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years - 100Years
All Genders
ID06805942

Study of Lipiodol Embolization to Treat Heel Pain from Plantar Fasciitis Minimally Invasive Treatment to Reduce Pain and Improve Foot Function

Led by IR Centers · Updated on 2025-02-03

10

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and feasibility of using Lipiodol ethiodized oil as an investigational embolic agent to treat pain caused by plantar fasciitis. This study focuses on a minimally invasive procedure called plantar fascia embolization PFE, aiming to reduce inflammation and pain in the heel area. The study will assess changes in pain levels and foot function over a six-month period following treatment. Participants will receive plantar fascia embolization using Lipiodol, which targets the blood vessels in the plantar fascia to reduce inflammation and pain. This study involves a single intervention group receiving this treatment. The procedure is designed to be minimally invasive and is administered once during the study period. During the study, participants will be monitored for changes in pain using the Visual Analog Scale VAS and improvements in foot function using the Foot and Ankle Ability Measure FAAM. Researchers will also watch for any side effects or safety concerns related to the treatment. The follow-up period lasts six months, allowing for thorough assessment of outcomes and participant well-being throughout the study.

CONDITIONS

Brief Title

Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

Research Team

S

Sindhuja Kommidi Clinical Research Coordinator, MS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here